<p><b>A.</b> MSP1<sub>19</sub>. <b>B.</b> MSP2. <b>C.</b> AMA1. <b>D.</b> MSP1<sub>19</sub>, MSP2 and AMA1(combined).</p
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...
<p>Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-1<sub>1...
Data are fitted using a loess smoother function and 95% confidence intervals (grey shaded area). RFT...
<p><b>A.</b> MSP1<sub>19</sub>. <b>B.</b> MSP2. <b>C.</b> AMA1. 0 = Sites with plasmodium prevalence...
<p>Seroprevalence to <i>P. falciparum</i> antigens MSP-1<sub>42</sub> and AMA-1 by age category with...
*<p>Table footnotes: In boldface the ages (4–5 months, 6–9 months, 6, 7, 8, 15, 16–18, 19–21 yrs) wi...
<p>Antibodies to recombinant AMA1 protein were tested by standard ELISA. Antibodies to specific AMA1...
<p>Bars indicate antibody prevalence in different age-groups, error bars the upper limit of the 95% ...
<p>Seroprevalence of pre and post pandemic sera by age-group, using the haemoagglutination inhibitio...
<p>Age-adjusted seroprevalence (blue solid lines) using appropriate reversible catalytic models. The...
Data are fitted using a loess smoother function and 95% confidence intervals. RFTAT control (orange)...
<p>Significant differences in the frequency of autoantibody titers:</p><p>*<20 v. 20–40;</p><p>**20–...
<p>The horizontal axis shows the age groups and the vertical axis shows seropositive individuals (%)...
<p>Associations are reported between anti-MSP1<sub>19</sub> or anti-AMA1 total IgG ELISA titer reado...
Seropositivity by age for the ELISA platform: Overall data 95%CI envelopes; inset graph shows the ov...
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...
<p>Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-1<sub>1...
Data are fitted using a loess smoother function and 95% confidence intervals (grey shaded area). RFT...
<p><b>A.</b> MSP1<sub>19</sub>. <b>B.</b> MSP2. <b>C.</b> AMA1. 0 = Sites with plasmodium prevalence...
<p>Seroprevalence to <i>P. falciparum</i> antigens MSP-1<sub>42</sub> and AMA-1 by age category with...
*<p>Table footnotes: In boldface the ages (4–5 months, 6–9 months, 6, 7, 8, 15, 16–18, 19–21 yrs) wi...
<p>Antibodies to recombinant AMA1 protein were tested by standard ELISA. Antibodies to specific AMA1...
<p>Bars indicate antibody prevalence in different age-groups, error bars the upper limit of the 95% ...
<p>Seroprevalence of pre and post pandemic sera by age-group, using the haemoagglutination inhibitio...
<p>Age-adjusted seroprevalence (blue solid lines) using appropriate reversible catalytic models. The...
Data are fitted using a loess smoother function and 95% confidence intervals. RFTAT control (orange)...
<p>Significant differences in the frequency of autoantibody titers:</p><p>*<20 v. 20–40;</p><p>**20–...
<p>The horizontal axis shows the age groups and the vertical axis shows seropositive individuals (%)...
<p>Associations are reported between anti-MSP1<sub>19</sub> or anti-AMA1 total IgG ELISA titer reado...
Seropositivity by age for the ELISA platform: Overall data 95%CI envelopes; inset graph shows the ov...
Proportion of clusters expected to reach seroprevalence levels of 50%, 70% and 90% by year of age, b...
<p>Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-1<sub>1...
Data are fitted using a loess smoother function and 95% confidence intervals (grey shaded area). RFT...